Cardinal Health will pay $ 13 million for Reuters to fix the U.S. coup case

Author: Nate Raymond

BOSTON (Reuters) – Drug dealer Cardinal health Inc (NYSE 🙂 has agreed to pay more than $ 13 million to solve allegations that doctors were beaten by federal health programs for buying paid pharmaceutical products, the U.S. Department of Justice said Monday.

U.S. Attorney Rachael Rollins (NYSE 🙂 in Boston said Ohio-based drug dealer had violated the False Claims Act by paying for medical practice blows “through discounts before.”

Cardinal Health approved certain events as part of a $ 13.125 million settlement, Rollins’ office said, although the company said in a statement that it did not accept liability as part of the deal.

He said he no longer offers term-based discounts in litigation litigation.

The Justice Department said Cardinal Health has been making payments to medical practices since 2013 before buying medicines that did not meet government restrictions in the form of discounts.

Under the Anti-Kickback Statute, drug distributors are prohibited from offering or paying any compensation to physicians who purchase medications purchased from the government’s Medicare-covered health insurance program.

The U.S. Attorney General’s Office of Health and Human Services said distributors could legally offer customers commercially available discounts in certain situations.

But the department said Cardinal’s payments did not meet those requirements because they were not identifiable from sales of pharmaceutical products or bonuses that customers did not actually earn.